RxDoctor Payments DataLook up a doctor →

William Evans, MD

Neurology · Ocean Springs, MSNPI 1619913761

Payments from drug & device makers

$57,814in general payments, 2019–2025

Across 1,668 payments — averaging $34.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$29K
  • AbbVie$4K
  • UCB, Inc.$2K
  • Novartis$2K
  • Acadia Pharmaceuticals Inc$2K
  • Amgen$2K
  • plus $17K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Biogen53$29,140
AbbVie(2 entities)287$3,954
UCB, Inc.121$2,283
Novartis116$1,889
Acadia Pharmaceuticals Inc108$1,788
Amgen(2 entities)81$1,785
EMD Serono, Inc.65$1,630
AstraZeneca(2 entities)55$1,226
Teva Pharmaceuticals USA, Inc.79$1,093
Genentech USA, Inc.50$1,079
Pfizer70$997
SK Life Science, Inc.43$934
Lundbeck LLC37$780
Eisai Inc.30$590
Sunovion Pharmaceuticals Inc.34$588
Bristol Myers Squibb32$575
Lilly USA, LLC36$545
Adamas Pharmaceuticals, Inc.32$532
Sanofi27$522
Johnson & Johnson(2 entities)22$515
Neurocrine Biosciences, Inc.20$414
Supernus Pharmaceuticals, Inc.33$345
Argenx US, Inc.16$317
Merz Pharmaceuticals, LLC13$287
TG Therapeutics, Inc.15$258
Microtransponder, Inc.2$246
Mallinckrodt Hospital Products Inc.9$231
CSL Behring11$220
MDD US Operations, LLC14$203
Arbor Pharmaceuticals, Inc.16$197
Biohaven Pharmaceutical Holding Company Ltd.12$194
Takeda Pharmaceuticals U.S.A., Inc.8$185
ANI Pharmaceuticals, Inc.9$175
Jazz Pharmaceuticals Inc.5$159
Boston Scientific3$157
Avanir Pharmaceuticals, Inc.11$156
Neurelis, Inc.10$153
Ipsen Biopharmaceuticals, Inc6$145
Tanabe Pharma America, Inc.8$122
Otsuka America Pharmaceutical, Inc.7$116
GE HealthCare7$112
Banner Life Sciences, LLC5$98
Amneal Pharmaceuticals LLC7$94
Amylyx Pharmaceuticals, Inc.4$93
Electromed, Inc.6$87
Upsher-smith Laboratories LLC6$87
Vanda Pharmaceuticals Inc.3$73
Acorda Therapeutics, Inc4$60
Biohaven Pharmaceuticals, Inc.2$39
Collegium Pharmaceutical, Inc.2$38
Revance Therapeutics, Inc.2$37
Alnylam Pharmaceuticals Inc.2$34
Inspire Medical Systems, Inc.1$33
Medtronic1$30
Kyowa Kirin, Inc.2$25
Ambu Inc.1$22
Coloplast1$22
Amicus Therapeutics, Inc.1$19
Axsome Therapeutics, Inc.1$19
Chiesi USA, Inc.1$18

How this compares

$57,814 in reported general payments places this provider in the 85th percentile of 111 neurology providers in Mississippi.

See all neurology providers in Mississippi

Medicare billing

Part B allowed, 2024
$104,729
Medicare patients
458
Services billed
1,340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Ocean Springs

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →